Maven ranked as one of Scotland’s most active investors

2013 saw Maven Capital Partners (Maven) enjoy its strongest year since it was launched in 2009.

Information compiled by Business Insider shows that Maven continues to be one of the most active investors in the UK having completed more deals than any banks last year. In fact Maven ranked second on the list, having made 21 investments over the calendar year and deploying £74 million in funds. Only Scottish Enterprise had completed more deals in 2013.

Bill Nixon, Managing Partner at Maven said “I think 2013 was the first year of real recovery since the great financial crisis. M&A activity increased, the market for IPOs opened up, property values outside London began to recover, banks started to lend again, and private equity activity levels surged. Maven has followed this trend of increased entrepreneurial activity which is reflected in the stats produced by Business Insider” 

“The prospects for Maven in 2014 look equally as bright at the moment, with a strong pipeline of new transactions due to complete in the first half of 2014.”

2013 was also a good year for the Scottish Loan Fund (SLF) as it has continued to support SMEs across Scotland. The Fund, which provides flexible funding solutions to businesses, is a viable alternative to bank funding or equally can also be used for additional finance that is complementary to existing senior debt. The SLF has now committed over £37 million to dynamic Scottish companies.

The figures provided by Business Insider demonstrate that the SLF is seen within Scotland as a vital alternative source of finance outwith of the traditional avenues of bank debt.

Andrew Craig, Partner at Maven and Fund Manager for the SLF added “These statistics reflect the drive and commitment of the Maven team to invest in and help build successful businesses across the length and breadth of Scotland. Whether it is equity finance or the provision of mezzanine loans, Maven and the SLF team look forward to supporting more ambitious Scottish SMEs in 2014 and beyond.”

Share this article